Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Testosterone's effects on COVID-19 are unclear and need more research.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Testosterone may influence COVID-19 severity and outcomes.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

COVID-19 can cause hair loss and nail changes in some patients.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

COVID-19 may cause temporary hair loss due to the body's immune response.

New therapies are being developed that target integrin pathways to treat various diseases.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.